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Abstract  
Depression is a prominent non-motor symptom in Parkinson’s disease (PD). Assessing 
depression in PD remains a challenge due to the overlap of somatic symptoms between 
depression and PD. Other neuropsychiatric manifestations associated with PD, such as 
cognitive decline, also complicate assessment of depression. Therefore it is critical to 
investigate the validity of depression rating scales for use in PD. This will allow evaluation of 
observer- and self- report instruments to be administered in neurologically ill geriatric 
populations such as PD, and identification of appropriate scales to use in cognitively 
challenged PD patients. The present review includes all studies examining the validity of 
depression rating scales in PD. It discusses the usefulness of thirteen depression rating scales 
in PD. The clinician-rated and widely used HAMD-17 and the self-report GDS scales are 
recommended for screening and measuring severity of depression in PD. The GDS-15 may 
be a preferred choice due to its brevity and ease of use design for older adults. Other valid 
and reliable instruments to use in PD include self-rated scales, such as the HADS-D, HDI, 
and the BDI, and the observer-report, MADRS. The CSDD displayed satisfactory validity 
and reliability for identification of PD patients with and without dementia. The PHQ-2, PHQ-
10, SDS, CES-D, UPDRS-Depression item, IDS-SR, and IDS-C each showed some evidence 
of validity or reliability, however further research on the psychometric properties of these 
scales when used in a PD population are required. 
Key words: Depression, Parkinson’s Disease, Rating scales, Review 
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Introduction  
 With many depression scales available for clinical use in psychiatric populations, it is 
important to investigate which scales are valid and appropriate for use in Parkinson’s disease 
(PD). It has been well established that several symptoms of depressive disorders overlap with 
other non-motor symptoms of PD (Gallagher and Schrag, 2012; Wishart and Macphee, 
2011). For example, somatic and neurovegetative difficulties such as fatigue, 
psychoagitation, impaired concentration, and insomnia are seen in both depression and PD. 
Overlap in symptoms is likely to cause difficulties in the accurate identification and diagnosis 
of depression in PD, hence contributing to both under-detection of cases as well as under-
treatment. The majority of rating scales used to assess depression consist of such overlapping 
symptoms, and therefore it is important to examine the validity of the use of depression rating 
scales in PD. For consistency of assessment and to enhance specificity, it has been suggested 
to use an “inclusive” approach when assessing depression in PD (Marsh et al., 2006), which 
involves rating of the presence or severity of the symptom regardless of the overlap with PD 
or other medical conditions.   
In clinical practice, patients undergoing assessment for psychiatric disorders such as 
depression should be interviewed using a standardised clinical interview based on diagnostic 
criteria, such as those from the Diagnostic Statistical Manual, Fifth Edition (DSM-5) 
(American Psychiatric Association, 2013). However, rating scales (either self-report, 
clinician-based, or informant-rated) are often used to screen for psychiatric symptoms and 
their severity and assist with eventual diagnosis. Often administration of rating scales is also 
more feasible than conducting interviews for the assessment of psychological disorders in 
epidemiological studies, surveys, and clinical trials. The use of brief, valid rating scales 
administered by clinicians and researchers is therefore vital in improving the detection of 
depressive disorders, which are highly prevalent in PD (Reijnders et al., 2008). 
Despite measuring the same overall psychological construct of depression, each rating 
scale is unique in what symptoms their items aim to assess. The aim of the present review is 
therefore to explore tools used to measure depression in PD to determine their reliability and 
validity in PD, in order to ascertain the most useful rating scales. A similar review was 
previously published by Schrag et al. in 2007. However since then a number of original 
articles focusing on depression rating scales in PD have been published. For example an 
original study by Williams et al. 2012 compared the utility of 9 depression rating scales in 
PD. This review is a comprehensive update of the literature pertaining to reliability and 
validity studies of all depression rating scales in PD, and provides as well an updated 
overview, based on this literature, of the utility of these measures in PD.   
A literature search was performed using PsycInfo, PubMed and Web of Science 
databases. The search terms included Parkinson* disease, psychiatric, depress*, assessment, 
scales, and valid*. No years were specified in the search, and therefore all years up until the 
present were included. The inclusion criterion for the literature review was review articles 
and studies that have investigated the validation of depression instruments in PD, and written 
in English. The results of the search revealed thirteen depression rating scales that have been 
used in PD. The structure of this review consists two parts for each scale. First is to provide 
general information about the scale and second is to comprehensively discuss validity and 
reliability details relating to PD. First part (general information) guides the reader to 
understand more about the scale when used in the general population, specially those who are 
unfamiliar with various rating scales used to measure depression. Second part clearly 
describes studies examining the validity and reliability in PD. For each scale, a brief 
conclusions as to whether the evidence suggests that the scale is appropriate for use in PD are 
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outlined. A summary of each depression scale reviewed and its usefulness in PD is provided 
in Table 4. 
 
Frequently used general depression rating scales 
Hamilton Depression Rating Scale (HAMD) 
 The HAMD was one of the first semi-structured interview measures developed for the 
clinical evaluation of depression in adults and remains the most widely used measure in 
clinical practice (Hamilton, 1960). There are multiple versions of the clinician-rated HAMD 
available, including 6-item, 17-item, 21-item, and 24-item scales (Serrano-Duenas and 
Soledad Serrano, 2008; Weintraub et al., 2006). The 17-item version (HAMD-17) is the most 
frequently used version. Each item is scored on a 3-point or 5-point scale, with higher scores 
indicating greater severity of symptoms. The HAMD exhibits good discriminant validity, 
test-retest reliability, inter-rater reliability, and good sensitivity to change in non-PD 
depressed patients (Bagby et al., 2004). One main criticism of the HAMD, however, is that 
somatic symptoms of depression are heavily represented in item content. 
 The reliability and validity of the HAMD in PD has been evaluated in a number of 
studies. The results from studies which have assessed the discriminant validity of the HAMD-
17 and HAMD-24 in PD are summarised in Table 1. An optimal HAMD-24 cut-off score for 
distinguishing between patients with and without a depressive disorder was found to be 9/10, 
with a high area under the curve (AUC) (0.91) indicating excellent discrimination (Weintraub 
et al., 2006). In this study, a depressive disorder indicated a diagnosis of major or minor 
depression according to the gold standard DSM-IV diagnostic criteria. Limitations of the 
study, however, include the relatively older mean age of patients in the sample (72 years) and 
the fact that it was a predominantly male sample. The researchers also did not include any 
cognitive assessment or exclude patients diagnosed with dementia. Leentjens et al. (2000a) 
investigated the discriminant validity of the HAMD-17, with results also indicating a high 
AUC (0.95) and suggesting an optimal cut-off score of 13/14. This study did not specify what 
a diagnosis of ‘depressive disorder’ included. To assess major depression an optimal cut-off 
of 12/13 was suggested by two studies (McDonald et al., 2006; Naarding et al., 2002), while 
Dissanayaka et al. (2007) suggested a higher cut-off of 18/19. The prevalence of major 
depression was lower in Dissanayaka et al. 2007 study, and this study suggested a cut-off of 
12/13 for depressive disorder (major depression, minor depression and dysthymia). A lower 
optimal cut-off of 6/7 was recently suggested by Williams et al. (2012). The inclusion of 
depressive subtypes resulting in a very high prevalence of depressive symptomatology (93%) 
may account for the low optimal cut-off value. 
Due to the overlap of somatic symptoms in both depression and PD, Reijnders et al. 
(2010) investigated the discriminant validity of the HAMD-17 and a modified version, in 
which items assessing somatic symptoms were excluded. The results showed that the 
modified version was reduced in specificity. It was therefore recommended that the original 
HAMD-17 is selected for assisting with diagnosing depression in PD, while an abbreviated 
version might be more appropriate for screening purposes. Overall, the HAMD-17 has 
displayed good validity and reliability, and is generally recommended for screening and 
measuring severity of depression in PD. 
 
Hamilton Depression Inventory (HDI) 
 The HDI is a self-rated version of the clinician-rated HAMD, and assesses the 
severity of depressive symptoms over the past two weeks (Dissanayaka et al., 2007; Reynolds 
and Kobak, 1995). There is a 23-item, 17-item, and 9-item version of this measure, however 
the 17-item scale remains analogous to the standard 17-item HAMD. Item scores on the HDI-
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17 can range from 0 to 2 or 0 to 4. The HDI has been validated and used in the general 
population, demonstrating high levels of reliability, content validity, criterion validity, 
construct validity, and clinical efficacy (Reynolds and Kobak, 1995). In PD, an optimal cut-
off score of 13.5/14.0 was suggested to discriminate between patients with and without 
depressive disorder (major depression, minor depression, or dysthymia according to the 
DSM-IV criteria) and 15.5/16 for major depression (Dissanayaka et al., 2007). The internal 
consistency of the HDI-17 was also satisfactory (Cronbach’s α = .85). Overall, the HDI-17 
appears to be an appropriate scale to screen and diagnose depressive disorders in PD. 
 
Beck Depression Inventory (BDI) 
 The BDI is a 21-item self-report assessment tool used to screen, diagnose, and 
measure severity of depression (Beck et al., 1961; Leentjens et al., 2000b). It is one of the 
most frequently used self-rated instruments for the assessment of major depression. There 
exist several adaptations of the BDI in accordance with DSM-IV criteria. The BDI-II, the 
second revision of the original BDI, included the addition of items to assess agitation, 
concentration difficulties, and loss of energy (Beck et al., 1996). There has been criticism that 
the BDI contains several somatic items, however the main focus of BDI items is on 
psychological symptoms of depression (Schrag et al., 2007). Each of the BDI items is scored 
from 0 to 3. The BDI has exhibited good test-retest reliability, internal consistency, 
concurrent validity, and discriminant validity in a variety of patient groups (Beck et al., 1961; 
Richter et al., 1998). 
 Studies which have assessed the discriminant validity of the BDI in PD are 
summarised in Table 2. Leentjens et al. (2000b) examined the validity of the BDI in a sample 
of 53 PD patients who were diagnosed with or without depression according to the SCID. 
Results indicated that the optimal cut-off score to discriminate between depressed and non-
depressed patients was 13/14 (AUC = 0.86), although it was concluded that the BDI should 
not be used to dichotomise based on a single cut-off score. A limitation of this study was that 
they did not specify what was included in the diagnosis of a ‘depressive disorder’. 
Visser et al. (2006) also reported an adjusted cut-off score of 14/15, with a high AUC 
(0.88) indicating good discriminant validity of the BDI for a diagnosis of major depression in 
PD. The test-retest reliability (r = 0.89) and internal consistency (Cronbach’s α = 0.88) were 
also good. Further studies have demonstrated that the BDI has good reliability and validity 
for the assessment of major depression or depressive disorders in PD (Levin et al., 1988; 
Schneider et al., 2010; Silberman et al., 2006; Williams et al., 2012). Overall, the BDI 
displays good validity and reliability for use in PD, and is recommended for screening and 
measuring severity of depression in this population. 
 
Hospital Anxiety and Depression Scale – Depression Subscale (HADS-D) 
 The HADS-D is a 7-item self-report subscale of the HADS which assesses symptoms 
of depression (Zigmond and Snaith, 1983). It was designed to assess the emotional aspects of 
depression (e.g. anhedonia) and excludes physical and cognitive symptoms, and suicidal 
ideation (Schrag et al., 2007). Respondents are required to rate the items on a 4-point scale, 
ranging from 0 to 3. In the assessment of non-PD patients, the HADS-D has displayed good 
internal consistency, test-retest reliability, and sensitivity to change in treatment (Bjelland et 
al., 2002; Herrmann, 1997). The discriminant and concurrent validity of the HADS-D were 
also satisfactory, however it has been criticised for having poor face validity due to exclusion 
of the items which assess the most severe symptoms of depression (Bjelland et al., 2002; 
Schrag et al., 2007).  
 The discriminant validity of the HADS-D was evaluated against the HAMD-17 in 
non-demented PD (Mondolo et al., 2006). A cut-off score to best distinguish between 
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depressed and non-depressed patients (according to HAMD-17 score) was 10/11, with a very 
high AUC (0.98). HADS-D has displayed good internal consistency and test-retest reliability 
(Marinus et al., 2002; Rodriguez-Blazquez et al., 2009), and appears to be a reliable 
instrument for screening depression in PD; however further research to assess the 
discriminant validity of the scale against DSM-5 criteria is required.   
 
Zung Self-Rating Depression Scale (SDS)  
 The SDS is a 20-item self-rated scale that screens for and measures the severity of 
psychological and somatic symptoms of depression (Schrag et al., 2007; Zung, 1965). Items 
on the scale represent most of the DSM-IV criteria for major depression, however there are a 
large number of somatic items that may overlap with symptoms from other health conditions 
such as PD (Schrag et al., 2007). Respondents are required to rate the frequency that each 
symptom affects their life, with items scored on a 4-point scale ranging from 1 = a little of the 
time to 4 = most of the time. There have been multiple shortened versions of the SDS, 
although the original remains the most frequently used. The SDS has displayed good internal 
consistency, test-retest reliability, content validity, and criterion validity, and acceptable 
concurrent validity (Kaneda, 1999; Zung et al., 1965).  
The Portuguese Brazilian version of the SDS appears to be valid and reliable to use in 
non-demented PD patients (Chagas et al., 2010). An optimal cut-off of 54/55 has shown to 
distinguish between depressed and non-depressed patients against the DSM-IV criteria, with 
a high AUC (0.93). It has displayed good concurrent validity with the GDS-15 (ρ = 0.65), 
however the internal consistency was moderate (Cronbach’s α = 0.73). The original English 
version of the SDS has been used to assess depression in PD, however this version of the 
scale has not been validated for use in PD (Kanda et al., 2008).  
 
Centre for Epidemiologic Studies Depression Scale (CES-D) 
 The CES-D is a brief, 20-item self-report scale that was developed to measure 
depressive symptomatology (Radloff, 1977). The items were derived from other validated 
depression scales to form a screening instrument for depression, particularly in older adults 
with physical illness. Respondents are required to indicate the frequency which they have 
experienced each depressive symptom over the past week on a 4-point scale, ranging from 0 
= rarely or none at all to 3 = most or all of the time. There are multiple versions of the CES-
D available, including a short adaptation for older adults, with all versions sharing similar 
psychometric properties (Andresen et al., 1994). The CES-D is reported to exhibit high 
internal consistency, adequate test-retest reliability, and good construct and discriminant 
validity (Parikh et al., 1988; Radloff, 1977). Williams et al. (2012) is the only study to 
investigate the validity and reliability of the CES-D in PD patients without cognitive decline. 
The results indicated that the internal consistency was high (Cronbach’s α = 0.92) and an 
optimal cut-off score was 11/12, with an AUC of 0.79. Overall, further research is required to 
investigate the reliability and validity of the CES-D for screening depression in PD. 
 
Montgomery-Asberg Depression Rating Scale (MADRS)  
 The MADRS is a 10-item clinician-rated scale and represent the full DSM-IV criteria 
of a major depressive episode, with the exception of hypersomnia, increased appetite, and 
psychomotor retardation or agitation (Montgomery and Asberg, 1979). It has exhibited good 
face validity, criterion validity, and concurrent validity, and high inter-rater reliability and 
internal consistency (Davidson et al., 1986; Montgomery and Asberg, 1979). While Leentjens 
et al. (2000a) found an optimal cut-off score of 14/15, with a high AUC (0.90), Silberman et 
al. (2006) showed a lower cut-off of 9/10 with a satifactory AUC (0.84). Both studies did not 
specify what constituted a diagnosis of ‘depression’. The results of Williams et al. (2012) 
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indicated an AUC of 0.88 and adequate internal consistency (Cronbach’s α = 0.83). As with 
the HAMD, Reijnders et al. (2010) investigated the discriminant validity of the original 
MADRS as well as a modified version with somatic symptoms excluded. It was concluded 
that the original version of the MADRS should be selected for assisting with diagnosing 
depression in PD and the abbreviated version of the MADRS might be more appropriate for 
brief screening. Overall, the MADRS appears to be a valid clinician-rated scale for the 
assessment of depression in PD. 
 
Infrequently used general depression rating scales 
Patient Health Questionnaires (PHQ-2 and PHQ-9)  
 The PHQ-9 is a self-rated assessment tool and is based on the DSM-IV criteria for 
major depression (Chagas et al., 2013; Kroenke et al., 2001). The items are scored on a 4-
point Likert scale, ranging from 0 = not at all to 3 = nearly every day. The PHQ-2 is a brief, 
clinician-rated scale and the two items assess whether patients have experienced ‘loss of 
interest or pleasure’ and ‘feeling down or hopeless’ (Chagas et al., 2011). In the general 
population, the PHQ-9 has exhibited good internal consistency, test-retest reliability, and 
criterion (discriminant) validity, while the PHQ-2 has also displayed satisfactory construct 
and criterion validity (Kroenke et al., 2001, 2003). In PD, both PHQ-9 and PHQ-2 have 
demonstrated high discriminant validity, and the optimal cut-off values to discriminate major 
depression were 8/9 and 2/3, respectively (Chagas et al., 2011; Chagas et al., 2013). An 
optimal cut-off of 5/6 for PHQ-9 has shown to appropriately discriminate between all 
subtypes of depression (Williams et al., 2012). The PHQ-9 has depicted adequate internal 
consistency, and moderate concurrent validity against the GDS-15 and SDS (Chagas et al., 
2013; Williams et al., 2012).  
 
Inventory of Depression Symptoms: Clinical and Self-Report (IDS-C and IDS-SR) 
 IDS scales assess for symptoms of major depression, and focus on frequency of 
symptoms, as opposed to intensity of symptoms. There are 28-item and, more recently, 30-
item versions of both of the IDS scales. Both item versions of the IDS-C and IDS-SR have 
demonstrated good psychometric properties, including adequate face validity, internal 
consistency, inter-rater reliability, concurrent validity, and discriminant validity (Rush et al., 
1986; Rush et al., 1996). With better item coverage, the 30-item version is suggested for the 
evaluation of depressive symptom severity. In PD, IDS-C and IDS-SR have demonstrated 
good internal consistency, and optimal cut-off values to discriminate between patients with 
and without major depression were 11/12 and 13/14, respectively (Williams et al., 2012).    
  
World Health Organisation (WHO)-Five Wellbeing Index (WHO-5) 
 The WHO-5 is a brief tool developed to measure the level of emotional well-being 
over a 2 week period (Schneider et al., 2010). Items focus on positive affect, and therefore 
lower scores indicate greater depressive symptoms. The WHO-5 has displayed good 
psychometric properties as a reliable screening tool for depression (Henkel et al., 2004; Lowe 
et al., 2004). This scale was suggested as an alternative to the commonly used BDI to quickly 
screen for low emotional well-being and depression in PD patients. WHO-5 has demonstrated 
good internal consistency, and an optimal cut-off of 12/13 has been suggested to distinguish 
PD patients with DSM-IV depressive disorders (Schneider et al., 2010).  
 
 
Depression rating scales developed for use in older adults  
Geriatric Depression Scale (GDS) 
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 The GDS is a brief, self-report measure, which focuses on non-somatic symptoms of 
depression, such as the psychological aspects (e.g. hopelessness) and social consequences of 
depression. It avoids inclusion of overlapping somatic symptoms (e.g. insomnia) 
(Dissanayaka et al., 2011; McDonald et al., 2006; Yesavage et al., 1982). The two commonly 
used versions of the instrument have 15 or 30-items. All items have a yes or no response set, 
scored as 0 or 1, and the instrument is easy to use. Psychometric properties of the GDS in 
depressed older adults without PD have demonstrated good discriminant validity, internal 
consistency and test-retest reliability. It was highly correlated with other depression rating 
scales (Schrag et al., 2007; Yesavage et al., 1982).  
 The studies which have assessed the discriminant validity of the GDS-15 or GDS-30 
in PD are summarised in Table 3. An optimal cut-off of 13/14 in GDS-30 was suggested to 
distinguish PD patients diagnosed with major and minor depression, and non-depressed 
patients (Ertan et al., 2005), while 9/10 was shown to distinguish patients with and without 
major depression (McDonald et al., 2006). The GDS-30 has also displayed strong internal 
consistency (Cronbach’s α =0.92) and split-half correlation coefficient (ρ = 0.91) (Ertan et al., 
2005). Further studies have provided support for the use of both versions of the GDS as a 
valid screen for depressive symptoms and to diagnose depression in PD (Dissanayaka et al., 
2007; Mondolo et al., 2006; Weintraub et al., 2006; Williams et al., 2012). The GDS-15 has 
been suggested a suitable tool to screen for major or minor depression in PD across all ages 
(Weintraub et al., 2007).  
 
Depression rating scales developed for use in dementia 
Cornell Scale for Depression in Dementia (CSDD) 
 The CSDD is a clinician-rated instrument developed specifically for the assessment of 
depression in patients with dementia (Alexopoulos et al., 1988a, b). Scoring is based on 
observation and interviews with the patient and an informant (frequently the patient’s 
caregiver). Informants are used to provide collateral information. The scale was developed to 
assess severity of depression, although it is also used for the screening of depression in 
dementia. Psychometric properties of the CSDD are acceptable, with satisfactory internal 
consistency, inter-rater reliability, concurrent validity, and sensitivity to change in the context 
of treatment (Alexopoulos et al., 1988a, b). It has been validated for the use in dementia and 
cognitively intact geriatric populations (Muller-Thomsen et al., 2005). 
 There are high prevalence rates of dementia in PD, therefore the CSDD is considered 
an appropriate and potentially useful tool to assess depression in patients with comorbid 
cognitive impairment (Schrag et al., 2007; Williams and Marsh, 2009). The content of the 
scale is also limited in terms of questions that might be associated with motor symptoms of 
PD, however there is some overlap with PD difficulties (e.g. psychomotor retardation). 
Williams and Marsh (2009) assessed the psychometric properties of the CSDD in 134 PD 
patients with and without dementia. Patients were categorised as having a depressive disorder 
if they met DSM-IV criteria for major depressive disorder, major depressive disorder in 
partial remission, minor depression, dysthymia, or depressive disorder not otherwise 
specified. The discriminant validity of the scale to distinguish which patients were identified 
as having a depressive disorder was moderate, with an optimal cut-off score of 7/8 and AUC 
of 0.82. Internal consistency of the CSDD was also acceptable (Cronbach’s α = 0.84). These 
results indicate that the CSDD is a valid tool for identifying depressive disorders across the 
cognitive spectrum in PD.  
 
Screening item only for assessment of depression 
Unified Parkinson’s Disease Rating Scale (UPDRS) Depression item 
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 The UPDRS widely used to assess the severity of PD includes a single observer-
report item to assess depressed mood on a 5-point scale ranging from 0 = normal to 4 = 
severe (Fahn et al., 1987; Goetz et al., 2008). This item has shown moderate concurrent 
validity against the HAMD, HADS-D, and GDS (Gallagher et al., 2012; Holroyd et al., 
2008). Except for the study by Chagas et al. (2011), other studies have indicated a low 
discriminat validity for the UPDRS-Depression item (Holroyd et al., 2008; Starkstein and 
Merello, 2007; Williams et al., 2012). Overall, the UPDRS-Depression item does not 
currently appear to be valid as a screening tool for depression. 
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Conclusion 
This review has provided an updated summary regarding the validity of existing 
depression rating scales for use with patients with PD. The results will benefit clinicians who 
require assessment of affective disorders in patients with PD, as it can assist them in choosing 
an appropriate scale for screening or to assist with the diagnosis of psychiatric disorders in 
this population. In situations where there are several scales with similar psychometric 
properties which are appropriate, it is understandable that a clinician or researcher would 
consider factors such as cost and convenience in selection of such a screening scale (Schrag 
and Leentjens, 2012). A summary of all depression rating scales discussed in this review is 
displayed in Table 4.  
Of the depression rating scales, the clinician-rated HAMD-17 displayed very good 
reliability and discriminant validity, and is recommended for screening and measuring 
severity of depression in PD. The optimal cut-off to discriminate patients with and without 
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depressive disorder for the HAMD-17 was 12/13 across a number of studies (Dissanayaka et 
al., 2007; McDonald et al., 2006; Naarding et al., 2002). The clinician-rated MADRS also 
exhibited very good validity and reliability in PD, although it did not appear to perform as 
well as the HAMD-17 in identifying depression in PD patients (Leentjens et al., 2000a). 
Reijnders et al. (2010) concluded, however, that the HAMD-17 and MADRS are suitable for 
diagnosing depression in PD, but that abbreviated versions of these scales, which exclude 
somatic symptoms, might be more appropriate for screening purposes. 
 The self-rated GDS-15 and GDS-30 were both found to have good validity and 
reliability and are recommended as screening tools for depression in PD. While both scales 
are designed for easy use in older adults who might have sensory or other impairments, 
clinicians may prefer to use the GDS-15 given it is shorter in length. The GDS-15 also 
appears to be appropriate for use in PD patients of all ages (Weintraub et al., 2007).  
Other self-rated scales which were found to display good validity and reliability for 
the use of screening or diagnosing severity of depression in PD included the HADS-D, HDI, 
and the BDI. The HADS-D also displayed sound test-retest reliability. The clinician-rated 
PHQ-2 and self-rated PHQ-9 were both found to be brief, valid, and reliable tools for 
screening depression in PD, as was the WHO-5. The Portuguese Brazilian version of the SDS 
also exhibited good validity and reliability as a screen for depression in PD, however more 
research on the original English version of the scale is required. For PD patients who appear 
to have cognitive impairment, the CSDD is recommended for use as it displayed satisfactory 
validity and reliability for identifying depression in patients with and without dementia. The 
CES-D, UPDRS-Depression item, IDS-SR, and IDS-C each showed some evidence of 
validity or reliability, however this was primarily investigated in the study by Williams et al. 
(2012), the results of which are likely to be impacted by recruitment bias. Further research on 
the psychometric properties of each of these scales is therefore required. We note that none of 
the original articles reviewed reported responsiveness, and an investigation of such 
information can also be a focus for future studies.  
 
Contributors 
Elizabeth Torbey: Conception, Organisation, Writing of the first draft, Review and critique  
Nancy Pachana: Conception, Review and critique  
Nadeeka Dissanayaka: Conception, Organisation, Writing of the first draft, Review and 
critique 
 
All authors have approved the final article.  
 
 
Acknowledgment 
We thank the Lions Medical Research Foundation for supporting Dr Nadeeka Dissanayaka’s 
fellowship. 
 
 
Role of the funding source 
 
Lions Medical Research Foundation supported Dr Dissanayaka’s salary. 
1 
 
References 
Alexopoulos, G.S., Abrams, R.C., Young, R.C., Shamoian, C.A., 1988a. Cornell Scale for 
Depression in Dementia. Biol Psychiat. 23, 271-284. 
Alexopoulos, G.S., Abrams, R.C., Young, R.C., Shamoian, C.A., 1988b. Use of the Cornell 
scale in nondemented patients. J Am Geriatr Soc. 36, 230-236. 
American Psychiatric Association, 2013. Diagnostic and statistical manual of mental 
disorders: DSM-5, 5th ed. American Psychiatric Association, Washington, DC. 
Andresen, E.M., Malmgren, J.A., Carter, W.B., Patrick, D.L., 1994. Screening for depression 
in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic 
Studies Depression Scale). Am J Prev Med. 10, 77-84. 
Bagby, R.M., Ryder, A.G., Schuller, D.R., Marshall, M.B., 2004. The Hamilton Depression 
Rating Scale: Has the gold standard become a lead weight? Am J Psychiat. 161, 2163-2177. 
Beck, A.T., Steer, R.A., Brown, G.K., 1996. Manual for the Beck Depression Inventory–II. 
Psychological Corporation, San Antonio, TX. 
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., 1961. An inventory for 
measuring depression. Arch Gen Psychiat. 4, 561-571. 
Bjelland, I., Dahl, A.A., Haug, T.T., Neckelmann, D., 2002. The validity of the Hospital 
Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 52, 69-77. 
Chagas, M.H., Crippa, J.A., Loureiro, S.R., Hallak, J.E., Meneses-Gaya, C., Machado-de-
Sousa, J.P., Rodrigues, G.R., Filho, A.S., Sanches, R.F., Tumas, V., 2011. Validity of the 
PHQ-2 for the screening of major depression in Parkinson's disease: Two questions and one 
important answer. Aging Ment Health. 15, 838-843. 
Chagas, M.H., Tumas, V., Loureiro, S.R., Hallak, J.E., Trzesniak, C., de Sousa, J.P., 
Rodrigues, G.G., Santos Filho, A., Crippa, J.A., 2010. Validity of a Brazilian version of the 
Zung self-rating depression scale for screening of depression in patients with Parkinson's 
disease. Parkinsonism Relat D. 16, 42-45. 
Chagas, M.H., Tumas, V., Rodrigues, G.R., Machado-de-Sousa, J.P., Filho, A.S., Hallak, 
J.E., Crippa, J.A., 2013. Validation and internal consistency of Patient Health Questionnaire-
9 for major depression in Parkinson's disease. Age Ageing. 42, 645-649. 
Davidson, J., Turnbull, C.D., Strickland, R., Miller, R., Graves, K., 1986. The Montgomery-
Asberg Depression Scale: Reliability and validity. Acta Psychiat Scand. 73, 544-548. 
Dissanayaka, N., O'Sullivan, J.D., Silburn, P.A., Mellick, G.D., 2011. Assessment methods 
and factors associated with depression in Parkinson's disease. J Neurol Sci. 310, 208-210. 
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P.A., O'Sullivan, J.D., 
Byrne, G.J., Mellick, G.D., 2007. Validity of Hamilton Depression Inventory in Parkinson's 
disease. Movement Disord. 22, 399-403. 
Ertan, F.S., Ertan, T., Kiziltan, G., Uygucgil, H., 2005. Reliability and validity of the 
Geriatric Depression Scale in depression in Parkinson's disease. J Neurol Neurosur Ps. 76, 
1445-1447. 
Fahn, S., Elton, R.L., UPDRS Program Members, 1987. Unified Parkinson’s disease rating 
scale, In: Fanh, S., Marsden, C.D., Goldstein, M., Calne, D.B. (Eds.), Recent developments in 
Parkinson's disease. Macmillan Healthcare Information, Florham Park, pp. 153–163. 
Gallagher, D.A., Goetz, C.G., Stebbins, G., Lees, A.J., Schrag, A., 2012. Validation of the 
MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Movement Disord. 27, 
79-83. 
Gallagher, D.A., Schrag, A., 2012. Psychosis, apathy, depression and anxiety in Parkinson's 
disease. Neurobiol Dis. 46, 581-589. 
Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez-Martin, P., 
Poewe, W., Sampaio, C., Stern, M.B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., 
2 
 
Kulisevsky, J., Lang, A.E., Lees, A., Leurgans, S., LeWitt, P.A., Nyenhuis, D., Olanow, 
C.W., Rascol, O., Schrag, A., Teresi, J.A., Hilten, J.J., LaPelle, N., 2008. Movement Disorder 
Society-Sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): 
Scale presentation and clinimetric testing results. Movement Disord. 23, 2129-2170. 
Hamilton, M., 1960. A rating scale for depression. J Neurol Neurosur Ps. 23, 56-62. 
Henkel, V., Mergl, R., Coyne, J.C., Kohnen, R., Moller, H.J., Hegerl, U., 2004. Screening for 
depression in primary care: Will one or two items suffice? Eur Arch Psy Clin N. 254, 215-
223. 
Herrmann, C., 1997. International experiences with the Hospital Anxiety and Depression 
Scale--a review of validation data and clinical results. J Psychosom Res. 42, 17-41. 
Holroyd, S., Currie, L.J., Wooten, G.F., 2008. Validity, sensitivity and specificity of the 
mentation, behavior and mood subscale of the UPDRS. Neurol Res. 30, 493-496. 
Kanda, F., Oishi, K., Sekiguchi, K., Kuga, A., Kobessho, H., Shirafuji, T., Higuchi, M., 
Ishihara, H., 2008. Characteristics of depression in Parkinson's disease: Evaluating with 
Zung's Self-Rating Depression Scale. Parkinsonism Relat D. 14, 19-23. 
Kaneda, Y., 1999. Usefulness of the Zung self-rating depression scale for schizophrenics. J 
Med Invest. 46, 75-78. 
Kroenke, K., Spitzer, R.L., Williams, J.B., 2001. The PHQ-9: Validity of a brief depression 
severity measure. J Gen Intern Med. 16, 606-613. 
Kroenke, K., Spitzer, R.L., Williams, J.B., 2003. The Patient Health Questionnaire-2: 
Validity of a two-item depression screener. Med Care. 41, 1284-1292. 
Leentjens, A.F., Verhey, F.R., Lousberg, R., Spitsbergen, H., Wilmink, F.W., 2000a. The 
validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and 
diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psych. 15, 644-649. 
Leentjens, A.F., Verhey, F.R., Luijckx, G.J., Troost, J., 2000b. The validity of the Beck 
Depression Inventory as a screening and diagnostic instrument for depression in patients with 
Parkinson's disease. Movement Disord. 15, 1221-1224. 
Levin, B.E., Llabre, M.M., Weiner, W.J., 1988. Parkinson's disease and depression: 
Psychometric properties of the Beck Depression Inventory. J Neurol Neurosur Ps. 51, 1401-
1404. 
Lowe, B., Spitzer, R.L., Grafe, K., Kroenke, K., Quenter, A., Zipfel, S., Buchholz, C., Witte, 
S., Herzog, W., 2004. Comparative validity of three screening questionnaires for DSM-IV 
depressive disorders and physicians' diagnoses. J Affect Disorders. 78, 131-140. 
Marinus, J., Leentjens, A.F., Visser, M., Stiggelbout, A.M., van Hilten, J.J., 2002. Evaluation 
of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin 
Neuropharmacology. 25, 318-324. 
Marsh, L., McDonald, W.M., Cummings, J., Ravina, B., 2006. Provisional diagnostic criteria 
for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Movement 
Disord. 21, 148-158. 
McDonald, W.M., Holtzheimer, P.E., Haber, M., Vitek, J.L., McWhorter, K., Delong, M., 
2006. Validity of the 30-item geriatric depression scale in patients with Parkinson's disease. 
Movement Disord. 21, 1618-1622. 
Mondolo, F., Jahanshahi, M., Grana, A., Biasutti, E., Cacciatori, E., Di Benedetto, P., 2006. 
The validity of the hospital anxiety and depression scale and the geriatric depression scale in 
Parkinson's disease. Behav Neurol. 17, 109-115. 
Montgomery, S.A., Asberg, M., 1979. A new depression scale designed to be sensitive to 
change. Brit J Psychiat. 134, 382-389. 
Muller-Thomsen, T., Arlt, S., Mann, U., Mass, R., Ganzer, S., 2005. Detecting depression in 
Alzheimer's disease: Evaluation of four different scales. Arch Clin Neuropsych. 20, 271-276. 
3 
 
Naarding, P., Leentjens, A.F., van Kooten, F., Verhey, F.R., 2002. Disease-specific properties 
of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and 
Parkinson's disease. J Neuropsych Clin N. 14, 329-334. 
Parikh, R.M., Eden, D.T., Price, T.R., Robinson, R.G., 1988. The sensitivity and specificity 
of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke 
depression. Int J Psychiat Med. 18, 169-181. 
Radloff, L.S., 1977. The CES-D scale: A self-report depression scale for research in the 
general population. Appl Psych Meas. 1, 385-401. 
Reijnders, J.S., Ehrt, U., Weber, W.E., Aarsland, D., Leentjens, A.F., 2008. A systematic 
review of prevalence studies of depression in Parkinson's disease. Mov Disord. 23, 183-189. 
Reijnders, J.S., Lousberg, R., Leentjens, A.F., 2010. Assessment of depression in Parkinson's 
disease: The contribution of somatic symptoms to the clinimetric performance of the 
Hamilton and Montgomery-Asberg rating scales. J Psychosom Res. 68, 561-565. 
Reynolds, W.M., Kobak, K.A., 1995. Reliability and validity of the Hamilton Depression 
Inventory: A paper-and-pencil version of the Hamilton Depression Rating Scale Clinical 
Interview. Psychol Assessment. 7, 472-483. 
Richter, P., Werner, J., Heerlein, A., Kraus, A., Sauer, H., 1998. On the validity of the Beck 
Depression Inventory. A review. Psychopathology. 31, 160-168. 
Rodriguez-Blazquez, C., Frades-Payo, B., Forjaz, M.J., de Pedro-Cuesta, J., Martinez-Martin, 
P., 2009. Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's 
disease. Movement Disord. 24, 519-525. 
Rush, A.J., Giles, D.E., Schlesser, M.A., Fulton, C.L., Weissenburger, J., Burns, C., 1986. 
The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiat Res. 
18, 65-87. 
Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B., Trivedi, M.H., 1996. The Inventory of 
Depressive Symptomatology (IDS): Psychometric properties. Psychol Med. 26, 477-486. 
Schneider, C.B., Pilhatsch, M., Rifati, M., Jost, W.H., Wodarz, F., Ebersbach, G., Djundja, 
D., Fuchs, G., Gies, A., Odin, P., Reifschneider, G., Wolz, M., Bottesi, A., Bauer, M., 
Reichmann, H., Storch, A., 2010. Utility of the WHO-Five Well-being Index as a screening 
tool for depression in Parkinson's disease. Movement Disord. 25, 777-783. 
Schrag, A., Barone, P., Brown, R.G., Leentjens, A.F., McDonald, W.M., Starkstein, S., 
Weintraub, D., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T., Goetz, C.G., 2007. 
Depression rating scales in Parkinson's disease: Critique and recommendations. Movement 
Disord. 22, 1077-1092. 
Schrag, A., Leentjens, A.F., 2012. Parkinson disease: Scales to detect depression in Parkinson 
disease. Nat Rev Neurol. 8, 359-360. 
Serrano-Duenas, M., Soledad Serrano, M., 2008. Concurrent validation of the 21-item and 6-
item Hamilton Depression Rating Scale versus the DSM-IV diagnostic criteria to assess 
depression in patients with Parkinson's disease: An exploratory analysis. Parkinsonism Relat 
Disord. 14, 233-238. 
Silberman, C.D., Laks, J., Capitao, C.F., Rodrigues, C.S., Moreira, I., Engelhardt, E., 2006. 
Recognizing depression in patients with Parkinson's disease: Accuracy and specificity of two 
depression rating scale. Arq Neuro-Psiquiat. 64, 407-411. 
Starkstein, S.E., Merello, M., 2007. The Unified Parkinson's Disease Rating Scale: Validation 
study of the mentation, behavior, and mood section. Movement Disord. 22, 2156-2161. 
Visser, M., Leentjens, A.F., Marinus, J., Stiggelbout, A.M., van Hilten, J.J., 2006. Reliability 
and validity of the Beck depression inventory in patients with Parkinson's disease. Movement 
Disord. 21, 668-672. 
4 
 
Weintraub, D., Oehlberg, K.A., Katz, I.R., Stern, M.B., 2006. Test characteristics of the 15-
item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. 
Am J Geriat Psychiat. 14, 169-175. 
Weintraub, D., Saboe, K., Stern, M.B., 2007. Effect of age on geriatric depression scale 
performance in Parkinson's disease. Movement Disord. 22, 1331-1335. 
Williams, J.R., Hirsch, E.S., Anderson, K., Bush, A.L., Goldstein, S.R., Grill, S., Lehmann, 
S., Little, J.T., Margolis, R.L., Palanci, J., Pontone, G., Weiss, H., Rabins, P., Marsh, L., 
2012. A comparison of nine scales to detect depression in Parkinson disease: Which scale to 
use? Neurology. 78, 998-1006. 
Williams, J.R., Marsh, L., 2009. Validity of the Cornell scale for depression in dementia in 
Parkinson's disease with and without cognitive impairment. Movement Disord. 24, 433-437. 
Wishart, S., Macphee, G.J., 2011. Evaluation and management of the non-motor features of 
Parkinson's disease. Ther Adv Chronic Dis. 2, 69-85. 
Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O., 1982. 
Development and validation of a geriatric depression screening scale: A preliminary report. J 
Psychiat Res. 17, 37-49. 
Zigmond, A.S., Snaith, R.P., 1983. The hospital anxiety and depression scale. Acta Psychiat 
Scand. 67, 361-370. 
Zung, W.W., 1965. A Self-Rating Depression Scale. Arch Gen Psychiat. 12, 63-70. 
Zung, W.W., Richards, C.B., Short, M.J., 1965. Self-rating depression scale in an outpatient 
clinic. Further validation of the SDS. Arch Gen Psychiat. 13, 508-515. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
Table 1: A summary of the studies which have assessed the discriminant validity of the 
HAMD-17 and HAMD-24 
Reference Version Participants Diagnosis AUC Cut-off scores 
Weintraub et 
al. (2006)  
      
HAMD-24 N = 148,  
mean age  
72 years, 
predominantly 
male 
SCID 0.91 Optimal: 9/10
a 
Screening: 9/10
a 
Diagnostic: 15/16
a 
      
Leentjens et al. 
(2000a) 
HAMD-17 N = 63,  
non-demented 
SCAN 0.95 Optimal: 13/14 
Screening: 11/12 
Diagnostic: 16/17 
      
Naarding et al. 
(2002) 
HAMD-17 N = 85,  
non-demented 
 
 
SCID-D 0.94 Optimal: 12/13
c 
Screening: 9/10
c 
Diagnostic: 15/16
c 
McDonald et 
al. (2006) 
HAMD-17 N = 50,  
non-demented 
 
SCID 0.82 Optimal: 12/13
c 
Dissanayaka et 
al. (2007) 
HAMD-17 N = 79,  
non-demented 
MINI-
Plus 
0.96 Optimal: 12/13
b 
Screening: 9/10
b 
Diagnostic: 14/15
b 
Optimal: 18/19
c 
      
      
Williams et al. 
(2012) 
HAMD-17 N = 229,  
non-demented 
SCID 0.86 Optimal: 6/7
d,e 
      
Note. 
a
Cut-off to differentiate between a diagnosis of depressive disorder (major depression or minor 
depression) versus no depressive disorder. 
b
Cut-off to differentiate between a diagnosis of a depressive disorder 
(major depression, minor depression, or dysthymia) versus no depressive disorder. 
c
Cut-off to differentiate 
between diagnosis of major depressive disorder or no major depressive disorder. 
d
Cut-off to differentiate 
between diagnosis of depression (major depression, major depressive episode in partial remission, minor 
depression, dysthymia, adjustment disorder with depressed mood, or depressive disorder not otherwise 
specified) and absence of depression. 
e
Williams et al. (2012) did not recommend a particular cut-off score for 
use in clinical practice. 
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Table 2: A summary of the studies which have assessed the discriminant validity of the BDI, 
BDI-1A, and BDI-II 
Reference Version Participants Diagnosis AUC Cut-off scores 
Leentjens et al. 
(2000b) 
BDI N = 53,  
non-demented 
SCID-D 0.86 Optimal: 13/14 
Screening: 8/9 
Diagnostic: 16/17 
      
Visser et al. 
(2006) 
BDI N = 92 ,  
non-demented 
SCID-D 0.88 Optimal: 14/15
a 
      
Silberman et al. 
(2006) 
BDI N = 46,  
mild-moderate 
PD severity,  
non-demented 
 
DSM-IV 
criteria 
0.80 Diagnostic: 17/18 
Schneider et al. 
(2010)  
BDI-1A N = 209,  
non-demented 
MINI 0.92
b 
0.90
c 
Optimal: 14/15
b 
      
Williams et al. 
(2012) 
 
BDI-II N = 229,  
non-demented 
SCID 0.85 Optimal: 6/7
d,e 
      
Note. 
a
Cut-off to differentiate between a diagnosis of major depressive disorder versus no major depressive 
disorder. 
b
Cut-off to differentiate between a diagnosis of a depressive disorder (major depression or minor 
depression) and no depressive disorder. 
c
Cut-off to differentiate between a diagnosis of a depressive disorder 
(major depression, minor depression, or dysthymia) and no depressive disorder. 
d
Cut-off to differentiate 
between a diagnosis of depression (major depression, major depressive episode in partial remission, minor 
depression, dysthymia, adjustment disorder with depressed mood, or depressive disorder not otherwise 
specified) and absence of depression. 
e
Williams et al. (2012) did not recommend specific cut-off scores for use 
in clinical practice.  
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Table 3: A summary of the studies which have assessed the discriminant validity of the GDS-
15 and GDS-30 
Reference Version Participants Diagnosis AUC Cut-off scores 
Ertan et al. 
(2005) 
GDS-30 N = 109,  
non-demented 
DSM-IV 
criteria 
0.89 Optimal: 13/14
a 
Screening: 8/9 or 9/10
a 
Diagnostic: 14/15 or 
15/16
a 
      
McDonald 
et al. (2006) 
GDS-30 N = 50,  
non-demented 
SCID 0.88 Optimal: 9/10
b 
 
      
Mondolo et 
al. (2006) 
GDS-30 N = 46,  
non-demented 
HAMD-
17 
0.90
 
 
Optimal: 10/11 
Screening: 10/11 
Diagnostic: 12/13 
      
Williams et 
al. (2012) 
 
GDS-30 N = 229,  
non-demented 
SCID 0.83 Optimal: 9/10
d,e 
      
Weintraub 
et al. (2006) 
GDS-15 N = 148,  
mean age 72 years, 
predominantly male 
SCID 0.92 Optimal: 4/5
a 
Screening: 4/5
a 
Diagnostic: 6/7
a 
      
Weintraub 
et al. (2007) 
GDS-15 N = 58 (< 65 years) 
N = 88 (65-75 years) 
N = 81 (> 75 years) 
SCID 0.92 
0.91 
.095 
Optimal: 4/5
a 
Optimal: 4/5
a 
Optimal: 5/6
a 
      
Dissanayaka 
et al. (2007) 
GDS-15 N = 79,  
non-demented 
MINI-
Plus 
0.91 Optimal: 6/7
c 
Screening: 4/5
c 
Diagnostic: 9/10
c 
Optimal: 8/9
b 
Note.
a
Cut-off to differentiate between a diagnosis of depressive disorder (major depression or minor depression) 
versus no depressive disorder. 
b
Cut-off to differentiate between a diagnosis of major depressive disorder versus 
no major depressive disorder. 
c
Cut-off to differentiate between a diagnosis of depressive disorder (major 
depression, minor depression, or dysthymia) and no depressive disorder. 
d
Cut-off to differentiate between 
diagnosis of depression (major depression, major depressive episode in partial remission, minor depression, 
dysthymia, adjustment disorder with depressed mood, or depressive disorder not otherwise specified) and 
absence of depression. 
e
Williams et al. (2012) did not recommend specific cut-off scores for use in clinical 
practice.  
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Table 4 
A Summary of all depression scales reviewed and their usefulness in PD 
Scale Number 
of 
validity 
studies 
Usefulness in PD Key References 
Hamilton Depression 
Scales -  17 & 24 item 
versions (HAMD-17 and 
HAMD-24) 
7 Good validity and reliability across 
versions. Recommended for 
screening and measuring severity 
of depression in PD.  
Leentjens et al. 
(2000a);  
Weintraub et al. 
(2006); 
Dissanayaka et 
al. (2007) 
    
Hamilton Depression 
Inventory (HDI)  
1 Good validity and reliability. 
Recommended for screening and 
diagnosis of depression in PD.  
Dissanayaka et 
al. (2007)  
    
Beck Depression 
Inventory (BDI)  
6 Good validity and reliability. 
Recommended for screening and 
measuring severity of depression in 
PD.  
Leentjens et al. 
(2000b); 
Visser et al. 
(2006);  
Schneider et al. 
(2010) 
    
Hospital and Anxiety 
Depression Scale – 
Depression subscale 
(HADS-D)  
3 Good reliability, but limitations 
associated with discriminant 
validity. Further research is 
warranted.  
Mondolo et al. 
(2006);  
Marinus et al. 
(2002) 
    
Zung Self-rating 
Depression Scale (SDS) 
–Brazilian version 
1 Brazilian version displayed good 
reliability and validity for 
screening of depression in PD. 
Further research of English version 
is warranted.  
Chagas et al. 
(2010);   
    
Centre for 
Epidemiologic Studies 
Depression Scale (CES-
D)  
1 Some evidence of reliability and 
validity, however further research 
is warranted.  
Williams et al. 
(2012)  
    
Montgomery-Asberg 
Depression Rating Scale 
(MADRS)  
4 Good discriminant validity. 
Recommended for assessment of 
diagnosis of depression in PD.  
Leentjens et al. 
(2000a); 
Silberman et al. 
(2006) 
    
Patient Health 
Questionnaires – 2 & 9 
item versions (PHQ-2 
and PHQ-9) – Brazilian 
versions 
3 Good discriminant validity across 
Brazilian versions and 
recommended as screening tool for 
depression in PD. Further research 
of English versions is warranted. 
Chagas et al. 
(2011);  
Chagas et al. 
(2013);  
Williams et al. 
(2012)  
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Inventory of Depression 
Symptoms – Self-Report 
(IDS-SR) and Clinician 
(IDS-C) 
1 Some evidence of reliability and 
validity across versions, however 
further research is warranted. 
Williams et al. 
(2012) 
    
WHO-Five (WHO-5) 1 Good reliability and discriminant 
validity. Recommended as a brief 
screening tool for depression in 
PD.  
Schneider et al. 
(2010)  
    
Geriatric Depression 
Scales – 15 & 30 item 
versions (GDS-15 and 
GDS-30) 
7 Good reliability and discriminant 
validity across versions. 
Recommended as a screening tool 
for depression in older PD patients, 
and possibly PD patients of all 
ages.  
Ertan et al. 
(2005);  
McDonald et al. 
(2006);  
Dissanayaka et 
al. (2007); 
Weintraub et al. 
(2007) 
    
Cornell Scale for 
Depression in Dementia 
(CSDD) 
1 Good reliability and discriminant 
validity. Recommended for 
identifying depression across 
cognitive spectrum in PD, but 
particularly for those with 
suspected cognitive decline.   
Williams and 
Marsh (2009)  
    
Unified Parkinson’s 
disease Rating Scale 
(UPDRS)-Depression 
item  
5 Evidence of concurrent validity, 
however further research is 
warranted. Mixed findings 
regarding discriminant validity of 
original UPDRS depression item. 
Gallagher et al. 
(2012); 
Starkstein and 
Merello (2007);  
Williams et al. 
(2012)  
 
 
Highlights 
 
 The present review updates recent literature focussed on depression rating scales in 
Parkinson’s disease (PD) 
 It discusses the usefulness of thirteen depression rating scales in PD.  
 The clinician-rated and widely used HAMD-17 and the self-report GDS scales are 
recommended for screening and measuring severity of depression in PD.  
 Other valid and reliable instruments to use in PD include self-rated scales, such as the 
HADS-D, HDI, and the BDI, and the observer-report, MADRS. The CSDD displayed 
satisfactory validity and reliability for identification of PD patients with and without 
dementia.  
 The PHQ-2, PHQ-10, SDS, CES-D, UPDRS-Depression item, IDS-SR, and IDS-C 
each showed some evidence of validity or reliability, however further research on the 
psychometric properties of these scales when used in a PD population are required. 
 
